OCUCYTE Trademark

Trademark Overview


On Tuesday, June 12, 2018, a trademark application was filed for OCUCYTE with the United States Patent and Trademark Office. The USPTO has given the OCUCYTE trademark a serial number of 87958656. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2019. This trademark is owned by Eyecure Therapeutics, Inc. (Jiangsu). The OCUCYTE trademark is filed in the Pharmaceutical Products category with the following description:

Biological tissue cultures for medical purposes; Cellular function activating agents for medical purposes; Chemical reagents for medical or veterinary purposes; Clinical medical reagents; Collyrium; Diagnostic reagents for medicinal use; Eye drops; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Irrigating solutions for eye use; Mixed biological preparations for the prevention and treatment of infectious diseases; Ophthalmic preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products for ophthalmological use; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues; Veterinary diagnostic reagents
ocucyte

General Information


Serial Number87958656
Word MarkOCUCYTE
Filing DateTuesday, June 12, 2018
Status700 - REGISTERED
Status DateTuesday, August 13, 2019
Registration Number5831312
Registration DateTuesday, August 13, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements


Goods and ServicesBiological tissue cultures for medical purposes; Cellular function activating agents for medical purposes; Chemical reagents for medical or veterinary purposes; Clinical medical reagents; Collyrium; Diagnostic reagents for medicinal use; Eye drops; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Irrigating solutions for eye use; Mixed biological preparations for the prevention and treatment of infectious diseases; Ophthalmic preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products for ophthalmological use; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues; Veterinary diagnostic reagents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 18, 2018
Primary Code005
First Use Anywhere DateFriday, December 1, 2017
First Use In Commerce DateFriday, December 1, 2017

Trademark Owner History


Party NameEyecure Therapeutics, Inc. (Jiangsu)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDistrict, Wuxi, 214101
CN

Party NameEyecure Therapeutics, Inc. (Jiangsu)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDistrict, Wuxi, 214101
CN

Party NameEyecure Therapeutics, Inc. (Jiangsu)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDistrict, Wuxi, 214101
CN

Trademark Events


Event DateEvent Description
Monday, December 31, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 15, 2018NEW APPLICATION ENTERED
Monday, June 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 27, 2018ASSIGNED TO EXAMINER
Monday, October 15, 2018NON-FINAL ACTION WRITTEN
Monday, October 15, 2018NON-FINAL ACTION E-MAILED
Monday, October 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 31, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 22, 2019ASSIGNED TO LIE
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED